Key Takeaways GE HealthCare received CE mark approval for its Carevance hemodynamic monitoring solution.GEHC says Carevance expands access to advanced care with fewer barriers and added insights.GE HealthCare expects Carevance to support flexible deployment amid rising care complexity.GE HealthCare Technologies Inc. (GEHC) announced the receipt of the CE mark for its Carevance patient monitor yesterday. This is expected to advance accessible and reliable care for more customers, starting in Europe.It is wor ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received CE mark for its Carevanceâ"¢ patient monitor, advancing accessible and reliable care for more customers starting in Europe. Built on GE HealthCare's clinical excellence, Carevance offers a clinically reliable and cost-effective solution with validated parameters and an intuitive, efficient workflow that can help empower care teams to stay focused on their patients. Hospitals today are facing new challenges, fro. ...

Core Insights - GE HealthCare has announced collaborations with The Queen's Health Systems and Duke Health to develop AI-driven hospital operations software [1] Group 1: Collaborations - The Queen's Health Systems in Honolulu, HI and Duke Health in Durham, NC are the two leading U.S. health systems collaborating with GE HealthCare [1] - These health systems will contribute their frontline expertise to inform the development of GE HealthCare's new software solution [1] Group 2: Product Development - The forthcoming solution will be a cloud-first Software as a Service (SaaS) offering [1] - This new software will be part of GE HealthCare's CareIntellect family [1]

Key Takeaways GE HealthCare launched CareIntellect for Perinatal to enhance clinical workflows in maternal care.GEHC developed the tool with HCA to integrate data and deliver insights at the point of care.GE HealthCare expects the launch to strengthen its PCS business and market position.GE HealthCare Technologies Inc. (GEHC) announced the launch of CareIntellect for Perinatal yesterday. It is a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear, actionable insights that will lik ...

GE HealthCare's digital strategy is cloud-first, AI-powered, and software-enabled—building intelligent hardware as well as standalone applications and software solutions to support better care delivery and enhanced patient outcomes. CareIntellect for Perinatal is part of the CareIntellect family of applications which use a common, cloud-first infrastructure running on the Amazon Web Services (AWS) cloud. Customers who adopt CareIntellect applications can quickly and easily install new capabilities and appli ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the University of Michigan. The results demonstrated the environmental and clinical benefits of End-tidal Control software and were presented at ANESTHESIOLOGY® 2025 taking place from October 10- 14, in San Antonio, Texas. End-tidal Control software supports the clinician in maintaini. ...

Core Insights - GE HealthCare (GEHC) has announced a strategic collaboration with Erasmus MC University Medical Center to evaluate next-generation total body PET/CT technology, aiming to enhance precision imaging and cancer care [1][8] - The partnership focuses on early disease detection, personalized treatment planning, and outcome monitoring through advanced imaging capabilities and AI-driven innovations [1][2] Company Developments - The collaboration is expected to accelerate breakthroughs in oncology and theranostics, improving the speed, clarity, and confidence in disease detection, staging, and treatment [2][4] - GEHC's market position in the molecular imaging segment is likely to strengthen, showcasing the clinical potential of its next-generation PET/CT technology [4][10] - The partnership will explore protocol optimization, dose reduction, and dynamic imaging capabilities, which can help accelerate regulatory approvals and drive adoption among hospitals [11][12] Financial Performance - GEHC currently has a market capitalization of $34.3 billion and an earnings yield of 6.03%, significantly higher than the industry's 0.09% [5] - In the last reported quarter, GEHC delivered an earnings surprise of 16.5% [5] Industry Outlook - The global cancer diagnostics market is projected to grow from $109.61 billion in 2024 to $155.07 billion by 2030, with a CAGR of 6.14% from 2025 to 2030, driven by the increasing prevalence of cancer and advancements in diagnostic technologies [13]

Chicago, Illinois GE HealthCare Technologies Inc. (GEHC) designs medical imaging and patient-monitoring products and related equipment and services. Valued at $34 billion by market cap, GEHC has a leading market share in imaging and ultrasound equipment. The company is set to announce its third-quarter results before the market opens on Wednesday, Oct. 29. Ahead of the event, analysts expect the healthcare major to deliver a profit of $1.05 per share, down 7.9% from $1.14 per share reported in the year-ag ...

消息一出，西门子当日股价应声上涨近3%，西门子医疗市值稳定在约520亿欧元。 这并非一次简单的股权操作，而是牵动着全球医疗科技产业格局的大事。 思宇MedTech认为这一新闻值得从两个维度来观察： 医疗科技是一个长期稳定增长的产业方向，但企业要想走得更大，需要成为 "时间的朋友" 。这不仅意味着耐心的资本投入，更意味着在关键时刻做出具有 前瞻性 的战略选择。 2025年10月2日，外媒报道西门子集团（Siemens AG）正在研究剥离其持有的西门子医疗（Siemens Healthineers）大部分股份。具体方式可能是通过直接分拆 （direct spinoff），即母公司不再保留股份，而是以实物股票形式按持股比例直接向全体股东派发。 在这篇文章中，思宇MedTech将重点剖析"GPS"——GE、Philips、Siemens 三大巨头的不同路径，并结合其历史背景和资本市场逻辑，为中国的集团企业在医疗业务 布局上提供一些参考与启示。 三足鼎立的异与同： GPS巨头的现状透视 在全球医疗科技产业中， 西门子医疗（Siemens Healthineers） 、 GE HealthCare 和 飞利浦（Phili ...

Oct 1, 2025 8:30 AM Eastern Daylight Time GE HealthCare to announce third quarter 2025 results on October 29, 2025 Share GE HealthCare CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor ...